Related Experiment Video

Updated: Nov 25, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.8K

MicroRNAs involved in the EGFR pathway in glioblastoma

Bin Xu1, Jie Mei2, Wei Ji1

  • 1Department of Neurosurgery, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, PR China.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|December 19, 2020
PubMed

Insights

MicroRNAs (miRNAs) offer new therapeutic strategies for glioblastoma (GBM) by targeting the epidermal growth factor receptor (EGFR) pathway. These small RNAs show promise as biomarkers for GBM diagnosis, prognosis, and treatment response.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Glioblastoma (GBM) is a highly aggressive primary brain tumor with poor patient prognosis despite current treatments.
  • MicroRNAs (miRNAs) are key regulators of gene expression involved in various cellular processes, including cancer development.
  • The epidermal growth factor receptor (EGFR) signaling pathway plays a critical role in GBM pathogenesis.

Purpose of the Study:

  • To review the role of miRNAs targeting the EGFR signaling pathway in glioblastoma occurrence and progression.
  • To explore the potential of these miRNAs as diagnostic and prognostic biomarkers for GBM.
  • To discuss their utility in predicting treatment resistance and therapeutic efficacy in GBM patients.

Main Methods:

  • Comprehensive literature review of studies investigating miRNAs, EGFR signaling, and glioblastoma.
  • Analysis of miRNA involvement in key GBM-related cellular functions regulated by EGFR.
  • Evaluation of current evidence for miRNA-based biomarkers in GBM diagnosis, prognosis, and treatment.

Main Results:

  • Specific miRNAs have been identified that modulate critical components of the EGFR signaling pathway in GBM.
  • Dysregulation of these miRNAs is linked to GBM proliferation, invasion, migration, angiogenesis, and apoptosis.
  • Emerging evidence suggests miRNAs targeting EGFR factors can serve as potential biomarkers for GBM management.

Conclusions:

  • MicroRNAs targeting the EGFR pathway represent a significant area of research for understanding and treating glioblastoma.
  • These miRNAs hold promise as novel biomarkers for improved glioblastoma diagnosis, prognosis assessment, and personalized therapy selection.
  • Further research into miRNA-based strategies could lead to improved therapeutic outcomes for glioblastoma patients.
Keywords:
EGFR signaling pathwayGlioblastomaPredictive biomarkersTreatmentmicroRNAs

More Related Videos

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

9.9K
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation13:36

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation

Published on: July 23, 2012

19.8K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.8K